At the time of writing, Atossa Therapeutics Inc [ATOS] stock is trading at $0.88, up 0.24%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ATOS shares have gain 11.33% over the last week, with a monthly amount glided 8.15%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Atossa Therapeutics Inc [NASDAQ: ATOS] stock has seen the most recent analyst activity on January 26, 2018, when Maxim Group initiated its Buy rating and assigned the stock a price target of $2.
For the past year, the stock price of Atossa Therapeutics Inc fluctuated between $0.55 and $1.66. Currently, Wall Street analysts expect the stock to reach $5 within the next 12 months. Atossa Therapeutics Inc [NASDAQ: ATOS] shares were valued at $0.88 at the most recent close of the market. An investor can expect a potential return of 468.18% based on the average ATOS price forecast.
Analyzing the ATOS fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.37, Equity is -0.36 and Total Capital is -0.32.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.8630 points at the first support level, and at 0.8465 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.9030, and for the 2nd resistance point, it is at 0.9265.
Ratios To Look Out For
It is important to note that Atossa Therapeutics Inc [NASDAQ:ATOS] has a current ratio of 12.67. In addition, the Quick Ratio stands at 12.67 and the Cash Ratio stands at 12.0.
Transactions by insiders
Recent insider trading involved QUAY STEVEN C, President & CEO, that happened on May 21 ’25 when 11239.0 shares were purchased. Director, Remmel H. Lawrence completed a deal on Mar 26 ’25 to buy 10000.0 shares.
